North America Optical Genome Mapping Market to Grow with a CAGR of 19.97% through 2028
Increase in the incidence of genetic disorders and
increase in the demand for precision medicine is expected to drive the North
America Optical Genome Mapping Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “North
America Optical Genome Mapping Market –Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the North
America Optical Genome Mapping Market stood at USD 53.19 million in 2022 and is
anticipated to grow with a CAGR of 19.97% in the forecast period, 2024-2028.
The awareness among individuals regarding Optical Genome Mapping has led to
favorable market conditions for the North America Optical Genome Mapping
market. Several factors contribute to the growth of various Optical Genome
Mapping products.
The increasing focus on precision medicine represents
another substantial catalyst for the optical genome mapping market. Precision
medicine seeks to customize medical interventions for individual patients by
considering their genetic characteristics. Optical genome mapping plays a
crucial part in detecting genetic variances and structural irregularities,
which are critical for determining the most efficient treatment methodologies.
With healthcare providers and pharmaceutical firms progressively embracing precision
medicine principles, the demand for optical genome mapping technologies is
anticipated to experience a significant upswing.
Researchers and scientists are progressively adopting
optical genome mapping technologies to investigate the structural variations
and intricacies within genomes. This technology offers the capability for
detailed DNA mapping, facilitating the identification of genetic mutations
responsible for diseases and offering valuable insights into diverse biological
processes. Given the pivotal role of genomics in personalized medicine and
pharmaceutical development, the demand for optical genome mapping tools is experiencing
steady growth.
In October 2023, Bionano Genomics announced that it
had entered into a collaboration with NVIDIA to develop an acceleration
platform for use in Bionano's optical genome mapping (OGM) workflow. The
collaboration is expected to significantly improve data processing speed while
reducing time and cost associated with secondary analysis of OGM data.
Progress in optical genome mapping technology has
resulted in enhanced precision, efficiency, and cost-efficiency. As this
technology matures, it becomes increasingly attainable for research
institutions, clinical labs, and healthcare facilities. The decreased expenses
associated with genome sequencing and mapping have rendered optical genome
mapping a practical choice for a wider array of applications.
In today's fast-paced world, Optical genome mapping
technology enables rapid and efficient analysis of genomic information. Unlike
traditional sequencing methods that require time-consuming library preparation
and data processing, optical genome mapping provides high-resolution maps of
DNA structures quickly. This efficiency is critical for meeting the growing
demand for timely genomic insights, especially in research and clinical
settings. In a world where the understanding of genetic variations and their impact
on health and disease is paramount, optical genome mapping excels. It's
particularly adept at detecting structural variations in the genome, which are
increasingly recognized as essential factors in various diseases, including
cancer and neurodevelopmental disorders. Rapid identification of these
variations aids in quicker disease diagnosis and treatment decisions. Optical
genome mapping plays a crucial role in the era of precision medicine, where
treatments are tailored to an individual's genetic profile. The technology's
ability to pinpoint genetic variations allows healthcare providers to select
the most effective therapies, optimizing patient outcomes and reducing the
trial-and-error approach in treatment.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "North America Optical Genome Mapping Market.”
Genome-wide association studies are instrumental in
identifying genetic variations associated with complex diseases. While SNP
(Single Nucleotide Polymorphism) arrays have been widely used in GWAS, they
have limitations in detecting structural variations. Optical genome mapping
supplements GWAS by enabling the identification of structural variations that
may contribute to disease susceptibility.
In recent times, Optical Genome Mapping excels at
detecting structural variations in the genome, such as insertions, deletions,
duplications, and translocations. This is crucial for understanding the genetic
basis of diseases, including cancer, autism, and rare genetic disorders. Recent
research has revealed the significance of structural variations in these
conditions, making Optical Genome Mapping an invaluable tool for precise
diagnosis and targeted treatments. In the field of oncology, Optical Genome Mapping
has gained prominence for its ability to provide comprehensive insights into
cancer genomes. Researchers and clinicians use it to identify genomic
alterations, including large-scale chromosomal rearrangements and copy number
variations, which play a critical role in cancer development and progression.
This information guides treatment decisions, personalized therapies, and the
development of novel cancer treatments. However, the High Initial Capital
Investment may hinder market growth. Moreover, challenges related to Competition
from Established Genomic Technologies and Data Analysis and Interpretation may
pose obstacles to the Optical Genome Mapping market in the near future.
The North America Optical Genome Mapping Market is
segmented into product, application, end-user, regional distribution, and
company.
Based on its product, the Optical genome mapping is a
data-intensive process that requires a continuous supply of consumables, such
as reagents, chemicals, and assay kits. Researchers and clinical laboratories
performing optical genome mapping experiments must regularly purchase these
consumables to ensure the seamless operation of their instruments and maintain
data quality. As a result, there is a consistent and recurring demand for
consumables in this market.
Sample preparation is a critical step in the optical
genome mapping workflow. Consumables like DNA extraction kits, purification
columns, and labeling reagents are essential for converting biological samples,
such as blood, tissue, or cultured cells, into a format suitable for optical
genome mapping. Researchers and diagnostic labs must consistently invest in
these consumables to prepare and process samples for analysis. Maintaining the
accuracy and reliability of optical genome mapping instruments is paramount.
Consumables like calibration standards, control samples, and quality control
reagents are routinely used to validate instrument performance and ensure the
consistency of results.
Based on region, United States segment is expected to
grow during the forecast period. The United States, with its robust
research and development infrastructure, leads the North America Optical Genome
Mapping Market. The country hosts numerous research institutions, universities,
and biotechnology companies at the forefront of genomics research. These
entities leverage optical genome mapping technology for a wide range of
applications, including cancer genomics, rare disease diagnosis, and precision
medicine. The United States is also home to key optical genome mapping
technology providers, contributing to its dominance in the market.
The Canada market is poised to be the fastest-growing
market, offering lucrative growth opportunities for Optical Genome Mapping
players during the forecast period. Factors such as Canada has been steadily
increasing its investments in genomics research, fostering collaborations
between research institutions and industry partners. The Canadian genomics
community is expanding its expertise in areas like structural genomics,
metagenomics, and environmental genomics, where optical genome mapping
technology is highly relevant. The Canadian government has demonstrated strong
support for genomics research and technology adoption. Funding initiatives and
research grants have encouraged the adoption of advanced genomics technologies
like optical genome mapping. Canada's biotechnology and healthcare sectors are
experiencing significant growth, providing a conducive environment for the
adoption of genomics technologies in clinical and research settings.
Major companies operating in North America Optical
Genome Mapping Market are:
- Bionano Genomics, Inc., US
- NabSys Inc., US
- Nucleome Informatics Pvt Ltd
- France Genomique
- Praxis Genomics
- PerkinElmer
- OpGen, Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Advancements in Genomic Research and increasing Demand
for Precision Medicine are key drivers of the Optical Genome Mapping market. In
recent years, the growing emphasis on precision medicine, which tailors medical
treatments based on individual genetic profiles, fuels the demand for optical
genome mapping. Moreover, the growing consumer emphasis on preventative
healthcare products has enhanced production and marketing efforts. To meet the
demands of the market, manufacturers are increasingly incorporating
cutting-edge technologies with high production efficiency. Rising consumer
acceptance and continuous product innovation will further ensure the growth of
the Optical Genome Mapping and supplements market in the coming years.,” said
Mr. Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“North America Optical Genome Mapping Market
Segmented By Product (Consumables, Instruments), By Application (Genome
Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype
Phasing, Others), By End-User (Research & Academic Institutions,
Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Others),
By Country, Competition, Forecast, Opportunities, 2018-2028F”, has evaluated
the future growth potential of North America Optical Genome Mapping Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in North America Optical Genome Mapping Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com